Naples Global Advisors LLC Has $1.59 Million Stock Position in Aflac Incorporated (NYSE:AFL)

Naples Global Advisors LLC lessened its holdings in Aflac Incorporated (NYSE:AFL) by 2.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 17,845 shares of the financial services provider’s stock after selling 425 shares during the quarter. Naples Global Advisors LLC’s holdings in Aflac were worth $1,594,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Mcdonald Partners LLC raised its stake in Aflac by 1.0% during the second quarter. Mcdonald Partners LLC now owns 23,142 shares of the financial services provider’s stock worth $2,067,000 after acquiring an additional 236 shares in the last quarter. Welch Group LLC increased its position in Aflac by 147.7% during the 2nd quarter. Welch Group LLC now owns 83,851 shares of the financial services provider’s stock worth $7,489,000 after purchasing an additional 50,000 shares in the last quarter. Blackston Financial Advisory Group LLC bought a new position in Aflac in the 2nd quarter valued at approximately $233,000. SteelPeak Wealth LLC lifted its stake in Aflac by 1.3% in the 2nd quarter. SteelPeak Wealth LLC now owns 24,815 shares of the financial services provider’s stock valued at $2,216,000 after purchasing an additional 319 shares during the last quarter. Finally, Baader Bank Aktiengesellschaft boosted its position in Aflac by 4.3% in the second quarter. Baader Bank Aktiengesellschaft now owns 7,948 shares of the financial services provider’s stock valued at $704,000 after buying an additional 328 shares in the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Trading Up 2.2 %

Aflac stock traded up $2.22 during trading hours on Friday, reaching $104.76. 2,613,116 shares of the company’s stock were exchanged, compared to its average volume of 2,230,034. The firm has a market capitalization of $59.53 billion, a PE ratio of 11.56, a PEG ratio of 2.76 and a beta of 0.95. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The firm’s 50 day simple moving average is $93.33 and its 200 day simple moving average is $86.86. Aflac Incorporated has a twelve month low of $72.78 and a twelve month high of $104.90.

Aflac (NYSE:AFL) last announced its earnings results on Wednesday, July 31st. The financial services provider reported $1.83 EPS for the quarter, beating the consensus estimate of $1.60 by $0.23. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $4.10 billion. During the same quarter in the prior year, the company earned $1.58 EPS. The firm’s revenue for the quarter was down .7% compared to the same quarter last year. Research analysts predict that Aflac Incorporated will post 6.48 earnings per share for the current year.

Aflac Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st will be paid a $0.50 dividend. The ex-dividend date is Wednesday, August 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.91%. Aflac’s dividend payout ratio is currently 22.08%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. JPMorgan Chase & Co. increased their price target on Aflac from $80.00 to $83.00 and gave the company a “neutral” rating in a research note on Tuesday, July 2nd. Piper Sandler increased their target price on Aflac from $95.00 to $100.00 and gave the company an “overweight” rating in a research report on Friday, June 28th. Citigroup boosted their price target on Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a report on Tuesday, July 23rd. Truist Financial lifted their target price on shares of Aflac from $82.00 to $100.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Finally, Bank of America upped their price target on shares of Aflac from $105.00 to $108.00 and gave the company a “buy” rating in a research report on Thursday, August 1st. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $90.62.

Insider Activity at Aflac

In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of Aflac stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total value of $197,880.00. Following the completion of the sale, the director now directly owns 18,158 shares of the company’s stock, valued at $1,796,552.52. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Aflac news, Director Charles D. Lake II sold 22,378 shares of Aflac stock in a transaction dated Tuesday, May 21st. The stock was sold at an average price of $87.47, for a total transaction of $1,957,403.66. Following the completion of the transaction, the director now owns 61,522 shares in the company, valued at approximately $5,381,329.34. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Thomas J. Kenny sold 2,000 shares of the stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total transaction of $197,880.00. Following the completion of the sale, the director now owns 18,158 shares of the company’s stock, valued at approximately $1,796,552.52. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.